# VENOSTENT, INC.: Process Validation and Commercialization of SelfWrap, a Bioabsorbable Wrap to Improve Dialysis Access Outcomes

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | VENOSTENT, INC. |
| Location | Houston, TX |
| Project | Process Validation and Commercialization of SelfWrap, a Bioabsorbable Wrap to Improve Dialysis Access Outcomes |
| Project number | 1SB1HL184448-01 |
| Mechanism | SB1 |
| Institute | National Heart Lung and Blood Institute |
| Award | $500,000 |
| Awarded | 2026-09-11 |
| Project period | 2026-09-15 to 2027-09-14 |
| UEI | WLHLGMAJEAQ3 |

## Why this score
- Award of $400K or more.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11316739). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.